$Illumina(ILMN)$ Many advancements in genetics are attributed to ILMN, the gene-sequencing leader with ~70% market share. Its tools and equipment are the standards of a vibrant, burgeoning industry. The question is, will ILMN grow with it? I believe so, but not in the short run. It suits value investors more.